SE7607325L - Forfarande for framstellning av 2-substituerade 1,3-diazacykliska foreningar - Google Patents

Forfarande for framstellning av 2-substituerade 1,3-diazacykliska foreningar

Info

Publication number
SE7607325L
SE7607325L SE7607325A SE7607325A SE7607325L SE 7607325 L SE7607325 L SE 7607325L SE 7607325 A SE7607325 A SE 7607325A SE 7607325 A SE7607325 A SE 7607325A SE 7607325 L SE7607325 L SE 7607325L
Authority
SE
Sweden
Prior art keywords
diazacyclic
associations
substituted
preparing
procedure
Prior art date
Application number
SE7607325A
Other languages
English (en)
Other versions
SE410734B (sv
Inventor
F Ishikawa
A Kosasayama
Y Watanabe
Y Abiko
K Kameda
S Ono
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Priority to SE7607325A priority Critical patent/SE410734B/sv
Publication of SE7607325L publication Critical patent/SE7607325L/sv
Publication of SE410734B publication Critical patent/SE410734B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
SE7607325A 1976-06-24 1976-06-24 Forfarande for framstellning av 2-substituerade imidazoliner med hypoglykemisk aktivitet SE410734B (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE7607325A SE410734B (sv) 1976-06-24 1976-06-24 Forfarande for framstellning av 2-substituerade imidazoliner med hypoglykemisk aktivitet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607325A SE410734B (sv) 1976-06-24 1976-06-24 Forfarande for framstellning av 2-substituerade imidazoliner med hypoglykemisk aktivitet

Publications (2)

Publication Number Publication Date
SE7607325L true SE7607325L (sv) 1977-12-25
SE410734B SE410734B (sv) 1979-10-29

Family

ID=20328313

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7607325A SE410734B (sv) 1976-06-24 1976-06-24 Forfarande for framstellning av 2-substituerade imidazoliner med hypoglykemisk aktivitet

Country Status (1)

Country Link
SE (1) SE410734B (sv)

Also Published As

Publication number Publication date
SE410734B (sv) 1979-10-29

Similar Documents

Publication Publication Date Title
SE431753B (sv) Analogifprfarande for framstellning av 2-piperazinyl-6,7-dimetoxikinazoliner
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
SE428470B (sv) Forfarande for framstellning av 5-(2-hydroxi-3-(3,4-dimetoxi fenetylamino))-propoxi-3,4-dihydrokarbostyril
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
AR224095A1 (es) Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3
NO770366L (no) Fremgangsm}te for fremstilling av meta-aryloksy-benzaldehyder.
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
SE7704139L (sv) Forfarande for framstellning av azofergemnen
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
SE429237B (sv) Forfarande for framstellning av 9,3",4"-tri-alkanoyl sf-837 m,-derivat
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
SE428017B (sv) Forfarande for framstellning av 2,6 - metano - 2h-l- bensoxocinderivat
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO147423C (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater.
SE426947B (sv) Forfarande for framstellning av 3,5,5-trimetyl-hexanoyl-ferrocen
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE426067B (sv) Forfarande for framstellning av 9-hydroxi-7,8,9,10-tetrahydro-6h-dibenso (b,d) pyraner och -pyranoner
NO772809L (no) Fremgangsm}te for fremstilling av 2,6-diterti{rt-butylfenol
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE431325B (sv) Forfarande for framstellning av 6-substituerade 2,3-dimetoxi-5-metyl-1,4-bensokinoner

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7607325-3

Effective date: 19930109

Format of ref document f/p: F